Finance

Beta
Lists
IKT:NASDAQ
Inhibikase Therapeutics Inc
$1.91
+2.14%
(+0.040) 1D
$1.92
+0.52% (+0.0100)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
$1.84
High
$1.93
Low
$1.84
Mkt. cap
252.18M
Avg. vol.
686.95K
Volume
3.82M
52-wk high
$2.26
52-wk low
$1.33
EPS
-$0.44
Beta
0.92
Shares outstanding
132.03M
No. of employees
35
Open
$1.84
High
$1.93
Low
$1.84
Mkt. cap
252.18M
Avg. vol.
686.95K
Volume
3.82M
52-wk high
$2.26
52-wk low
$1.33
EPS
-$0.44
Beta
0.92
Shares outstanding
132.03M
No. of employees
35
News stories
From sources across the web
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteinhibikase.com
Analyst ratings
Based on 6 analysts giving stock ratings to IKT in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IKT in the last 3 months.
Highest
Current $1.91
$8.00 (+318.85%)
Average
$6.00 (+214.14%)
Lowest
$4.00 (+109.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mazahir Alimohamed
Oppenheimer
Buy
Initiated
$5.00
+161.8%
06/10/2026
Jason Zemansky
Bank of America Securities
Buy
Reiterated
$6.00
+214.1%
06/03/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$8.00
+318.8%
05/26/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
$4.00
+109.4%
05/18/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$5.00
+161.8%
05/16/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+318.8%
05/15/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$4.00
+109.4%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
5.27M
7.65M
-23.43M
-
Cost of revenue
5.27M
7.65M
-23.43M
-
Research and development expenses
-
-
22.39M
10.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.92M
5.61M
6.77M
7.38M
Operating expense
5.56M
5.61M
29.17M
18.22M
Total operating expenses
10.83M
13.26M
5.73M
18.22M
Operating income
-10.83M
-13.26M
-5.73M
-18.22M
Other non operating income
-
-
-
1.46M
EBT including unusual items
-9.92M
-11.93M
-12.73M
-16.38M
EBT excluding unusual items
-9.92M
-12.42M
-4.69M
-16.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-358.42K
-
-
-
Net income
-9.92M
-11.93M
-12.73M
-16.38M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.10
Interest and investment income
916.76K
838.09K
1.04M
-
Interest expense
-
-
-
-
Net interest expenses
916.76K
838.09K
1.04M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.81M
-13.24M
-5.73M
-18.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of IKT
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer